Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Pena, Loren; Baron, Richard; Byrne, Barry et al.

Phase 1 exploratory efficacy of the novel enzyme replacement therapy neoGAA in treatment-naive and alglucosidase alfa-treated late-onset Pompe disease patients

MOLECULAR GENETICS AND METABOLISM. Bd. 117. H. 2. 2016 S. S92-S92


Ladha, Shafeeq; Laforet, Pascal; Mengel, Eugen et al.

Phase 1 safety and pharmacokinetics of the novel enzyme replacement therapy neoGAA in treatment-naive and alglucosidase alfa-treated late-onset Pompe disease patients

MOLECULAR GENETICS AND METABOLISM. Bd. 117. H. 2. 2016 S. S117-S118


Viardot, Andreas; Goebeler, Marie-Elisabeth; Hess, Georg et al.

Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma

BLOOD. Bd. 127. H. 11. 2016 S. 1410-1416


Fergelot, Patricia; Van Belzen, Martine; Van Gils, Julien et al.

Phenotype and Genotype in 52 Patients with Rubinstein-Taybi Syndrome Caused by EP300 Mutations

AMERICAN JOURNAL OF MEDICAL GENETICS PART A. Bd. 170. H. 12. 2016 S. 3069-3082


Schmidt, Cornelia S.; Lopez, Pamela Aranda; Dopheide, Joern F. et al.

Phenotypic and functional characterization of neutrophils and monocytes from patients with myelodysplastic syndrome by flow cytometry

CELLULAR IMMUNOLOGY. Bd. 308. 2016 S. 19-26


Bens, Susanne; Kolarova, Julia; Beygo, Jasmin et al.

Phenotypic spectrum and extent of DNA methylation defects associated with multilocus imprinting disturbances

EPIGENOMICS. Bd. 8. H. 6. 2016 S. 801-816


Heeb, R

Phosphatbinder

Medizinische Monatszeitschrift. Bd. 39. 2016 S. 255-260



Eggebrecht, L.; Schleuter, L.; Goebel, S. et al.

Physician Survey on health Care with oral Anticoagulants- Results of the thrombEVAL- Study Programs

INTERNIST. Bd. 57. 2016 S. S5-S5


Kim, S; Thiesen, J; Krämer, I

Physicochemical Stability of Mozobil® (Plerixafor) Solution for Injection in Glass Vials and Plastic Syringes over a Three-Month Storage Period

Pharmaceutical Technology in Hospital Pharmacy. Bd. elektronisch. 2016 S. 0